EAST HANOVER, N.J., April 6, 2024 /PRNewswire/ -- Novartis today announced new data demonstrating the early addition of twice-yearly* Leqvio ® (inclisiran) to maximally tolerated statin therapy, prior ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. It’s a math problem with life-and-death ...

New evidence hints that statins may protect a wider range of people with type 2 diabetes than previously assumed. A major ...

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...

New research suggests statins may protect adults with type 2 diabetes regardless of how low their predicted heart risk appears. In a large UK study, statin use was linked to fewer deaths and major ...

The polypill offers a cost-effective solution for CVD management in underserved populations, potentially reducing health disparities. The intervention is projected to cost $8560 per QALY gained, ...

The debate continues as to whether or not statins have effects other than those that lower lipids that may provide additional cardiovascular benefits. An array of proposed pleiotropic effects have ...

Statins are among the most commonly prescribed medications for reducing high cholesterol and lowering the risk of heart attack and stroke. People searching for popular statin medications are often ...

SILVER SPRING, Md., Dec 13 (Reuters) - A Merck & Co Inc study failed to show that consumers could make appropriate decisions about whether to take a proposed over-the-counter version of cholesterol ...